<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Generex Biotechnology Corp. | Company News & Executive Profiles - GNBT | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/generex+biotechnology+corp..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Generex Biotechnology Corp.]]></description>
	<s:counts start="0" returned="10" found="32" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Oral-lyn vs. Afresa: How Generex Will Beat Mannkind]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F174252-oral-lyn-vs-afresa-how-generex-will-beat-mannkind%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[R.J Steffens submits: As biotech companies and large pharma embark on paths to usher in more effective diabetes drugs to market, one of the more significant concerns regarding diabetes related drug development is safety. The FDA has increasingly issued new alerts from previously approved drugs such as GlaxoSmithKline's GSK Avandia,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 19 Nov 2009 04:19:20 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/r.j+steffens.html"><![CDATA[R.J Steffens]]></category>
		<category domain="http://resources.bnet.com/topic/generex+biotechnology+corp..html"><![CDATA[Generex Biotechnology Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="tickers">GNBT,MNKD</category>
	</item>
	<item>
		<title><![CDATA[A N.I.C.E. Development for Generex Oral-lyn in the U.K.]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F167127-a-n-i-c-e-development-for-generex-oral-lyn-in-the-u-k%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[R.J Steffens submits: The United Kingdom's National Institute for Health and Clinical Excellence NICE has recently begun the draft scope for the official Health Technology Appraisal of Generex's GNBT novel buccal insulin for the management of type 1 diabetes. Oral-lyn is not yet licensed for sale in the UK. Oral-lyn...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 18 Oct 2009 05:14:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/r.j+steffens.html"><![CDATA[R.J Steffens]]></category>
		<category domain="http://resources.bnet.com/topic/generex+biotechnology+corp..html"><![CDATA[Generex Biotechnology Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
		<category domain="tickers">GNBT</category>
	</item>
	<item>
		<title><![CDATA[Liking the Risk/Reward in Generex]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F166093-liking-the-risk-reward-in-generex%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of Generex touched just above seventy six cents on above average volume on Monday morning after a New York Times article over the weekend highlighted the company's Ora-Lyn insulin spray product that uses the inside lining of the cheek to deliver insulin to the bloodstream. Mannkind's...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 12 Oct 2009 02:47:01 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/generex+biotechnology+corp..html"><![CDATA[Generex Biotechnology Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="tickers">GNBT,MNKD</category>
	</item>
	<item>
		<title><![CDATA[Genentech and Generex: New HER2/neu Research]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F110737-genentech-and-generex-new-her2-neu-research%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[R.J Steffens submits: This year's San Antonio Breast Cancer Symposium contained many studies that pertain to HER2/neu treatment.  Current  treatment revolves around Genentech's DNA Herceptin, but the event brings together many researchers who present their findings and a glimpse of improved future HER2/nue cancer treatment options.  Large...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 15 Dec 2008 04:39:36 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/rj+steffens.html"><![CDATA[RJ Steffens]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/generex+biotechnology+corp..html"><![CDATA[Generex Biotechnology Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
		<category domain="tickers">DNA,GNBT</category>
	</item>
	<item>
		<title><![CDATA[Four Drug Companies Vying for Diabetes Patients]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F91312-four-drug-companies-vying-for-diabetes-patients%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[R.J Steffens submits: The American Association of Diabetes Educators [AADE] released results last week at its high profile 35th Annual Meeting from an innovative new survey entitled the "Injection Impact Report".   The report highlights the level of communication between patients and healthcare providers relating to insulin injections and...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 17 Aug 2008 06:06:52 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/generex+biotechnology+corp..html"><![CDATA[Generex Biotechnology Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/nuvo+network+management+inc..html"><![CDATA[NUVO Network Management Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVO</category>
		<category domain="tickers">LLY,GNBT,NVO</category>
	</item>
	<item>
		<title><![CDATA[Turning Pennies into dollars: (Pink Sheets: STHG), (Nasdaq: GNBT), (OTCBB: JUNI), (OTCBB: PLTG).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200803/ai_n25268285]]></link>
		<description><![CDATA[M2 PRESSWIRE-27 March 2008-RealPennies.com: Turning Pennies into  dollars: (Pink Sheets: STHG), (Nasdaq: GNBT), (OTCBB: JUNI), (OTCBB:  PLTG).C1994-2008 M2 COMMUNICATIONS LTD     RDATE:27032008     Are you a public company looking for exposure? Contact  RealPennies.com - 1.800.940.6559     For more...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 27 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/generex+biotechnology+corp..html"><![CDATA[Generex Biotechnology Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/india.html"><![CDATA[India]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">GNBT,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Before the Bell Report for Wednesday, March 26th, 2008 - On the Radar:.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200803/ai_n25267798]]></link>
		<description><![CDATA[M2 PRESSWIRE-26 March 2008-The Micro Cap Opportunity: Before the  Bell Report for Wednesday, March 26th, 2008 - On the Radar:C1994-2008  M2 COMMUNICATIONS LTD    RDATE:26032008    LOS ANGELES - This morning's On the Radar' Micro Cap  trading candidates include, Home Solutions of America,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 26 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/dsl.html"><![CDATA[DSL]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/generex+biotechnology+corp..html"><![CDATA[Generex Biotechnology Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/india.html"><![CDATA[India]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[investor]]></category>
		<category domain="http://resources.bnet.com/topic/nasd.html"><![CDATA[NASD]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[security]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/telecommunications.html"><![CDATA[TELECOMMUNICATIONS]]></category>
		<category domain="http://resources.bnet.com/topic/turbine.html"><![CDATA[turbine]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
		<category domain="tickers">GNBT</category>
	</item>
	<item>
		<title><![CDATA[Speak with other shareholders about: (Nasdaq: GNBT), (OTCBB: JUNI), (OTCBB: PLTG).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200803/ai_n25267886]]></link>
		<description><![CDATA[M2 PRESSWIRE-26 March 2008-Stockwire.com: Speak with other  shareholders about: (Nasdaq: GNBT), (OTCBB: JUNI), (OTCBB:  PLTG).C1994-2008 M2 COMMUNICATIONS LTD     RDATE:26032008     AUSTIN, TX -- Are you looking to speak with other investors about  your favorite stock in real-time? Stockwire.com, ranked in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 26 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/compensation.html"><![CDATA[compensation]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/generex+biotechnology+corp..html"><![CDATA[Generex Biotechnology Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/india.html"><![CDATA[India]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[investor]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/shareholder.html"><![CDATA[shareholder]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">GNBT,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Stock Market Alerts: Special Alert and Coverage Issued for RBRM! September 19, 2007]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200709/ai_n19524915]]></link>
		<description><![CDATA[Stock Market Alerts' performance stock list includes: ReBuilder Medical Technologies, Inc. (PINKSHEETS: RBRM), Generex Biotechnology Corp. (NASDAQ: GNBT), Medtronic, Inc. (NYSE: MDT), Novavax, Inc. (NASDAQ: NVAX).  Having just announced yesterday morning it has reached $1.5 million in sales, ReBuilder Medical Technologies, Inc. (PINKSHEETS: RBRM) should have investors monitoring the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 19 Sep 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/generex+biotechnology+corp..html"><![CDATA[Generex Biotechnology Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
		<category domain="tickers">GNBT</category>
	</item>
	<item>
		<title><![CDATA[Growth Watch.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200707/ai_n19771194]]></link>
		<description><![CDATA[M2 PRESSWIRE-10 July 2007-Bullishalerts.com: Growth  WatchC1994-2007 M2 COMMUNICATIONS LTD    RDATE:10072007    Philadelphia, PA - Bullish Alerts is currently monitoring the  following Stocks: Ocean Bio-Chem, Inc. Nasdaq OBCI, Applied Micro  Circuits Corporation (Nasdaq: AMCC), Cell Genesys, Inc. (Nasdaq: CEGE)  and Generex Biotechnology...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 10 Jul 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cell+genesys+inc..html"><![CDATA[Cell Genesys Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/components.html"><![CDATA[Components]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/generex+biotechnology+corp..html"><![CDATA[Generex Biotechnology Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/processors.html"><![CDATA[Processors]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/semiconductors.html"><![CDATA[Semiconductors]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CEGE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CEGE,GNBT,NDAQ</category>
	</item>
</channel>
</rss>
